As China’s biotech firms shift gears, can AI floor the accelerator?
A quarter featuring multiple eye-popping deals is no longer unusual for China’s pharmaceutical industry – in fact, it…
Capital injection: China backs AI drug makers in self-reliance drive
Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan (US$57.9 million) in series D financing in August…